Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immediate Effects of STENDO on the Walking Abilities of Patients with COPD

NCT05618509 is registered in ClinicalTrials.gov with Elsan as lead sponsor.

NCT NCT05618509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05618509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immediate Effects of STENDO on the Walking Abilities of Patients with COPD
Lead sponsor
Elsan
Phase
Not applicable
Overall status
Completed
Start date
January 4, 2023
Completion date
May 27, 2024
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd, walking performance